Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thomas M. who wrote (4997)	8/10/2001 2:36:13 PM
From: Biomaven	Read Replies (1) of 10280

Tom, A boo-boo by the WSJ. As you say Clarinex is a non-sedating antihistamine, not an asthma drug. The FDA is holding up a drug that isn't directly related to the manufacturing problems because it is the biggest club they have. (They presumably didn't want to hold up Peg-Intron which was recently approved because there is a medical need for it). I read that the FDA is also threatening a suit against SGP for disgorgement of profits. Conceivably SGP could settle this and get Clarinex released at the same time. However I don't see that happening until a new FDA commissioner is in place. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next